Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC
about
Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC
description
scientific article published on 24 November 2019
@en
name
Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC
@en
type
label
Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC
@en
prefLabel
Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC
@en
P2093
P356
P1433
P1476
Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC
@en
P2093
Alessandro Marra
Birthe Heitkötter
Dennis Görlich
Georg Evers
Jan Rehkämper
Lars Henning Schmidt
Ludger Hillejan
Michael Mohr
Peter J Barth
Sebastian Huss
P304
P356
10.1111/1759-7714.13248
P577
2019-11-24T00:00:00Z